BCL2 and B-cell non-Hodgkin lymphoma: The debate about research into aggressive mature B-cell lymphomas with MYC, BCL2 and/or BLC6 aberrations, defined as high-grade B-cell lymphoma with double or triple hit (HGBL-DH/TH), deserves a special section as their detection constitutes a principal goal according to the last WHO classification [76].